부산대학교 도서관

Clarke H; Seagen Inc., Cell Line Development, Bothell, Washington, USA.; Mayer-Bartschmid A; Bayer AG, Biologics Development, Wuppertal, Germany.; Zheng C; Incyte Corporation, Cell Line Development, Wilmington, Delaware, USA.; Masterjohn E; Sanofi, Cell Line Development, Framingham, Massachusetts, USA.; Patel F; AbbVie Inc., S&T Biologics Development & Launch, Worcester, Massachusetts, USA.; Moffat M; Pfizer, Cell Line Development, Chesterfield, Missouri, USA.; Wei Q; Incyte Corporation, Cell Line Development, Wilmington, Delaware, USA.; Liu R; Merck & Co., Inc., Process Cell Sciences, Rahway, New Jersey, USA.; Emmins R; GSK Medicines and Research Centre, Cell Line Development, Stevenage, UK.; Fischer S; Boehringer Ingelheim Pharma GmbH & Co. KG, Cell Line Development, Biberach, Germany.; Rieder S; AbbVie Inc., S&T Biologics Development & Launch, Worcester, Massachusetts, USA.; Kelly T; Janssen R&D, Cell Engineering & Analytical Sciences, Spring House, Pennsylvania, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8506292 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6033 (Electronic) Linking ISSN: 15206033 NLM ISO Abbreviation: Biotechnol Prog Subsets: MEDLINE

Ikegami M; Carter K; Bishop K; Yadav A; Masterjohn E; Brondyk W; Scheule RK; Whitsett JA; Ikegami, Machiko; Carter, Karen; Bishop, Kimberly; Yadav, Annuradha; Masterjohn, Elizabeth; Brondyk, William; Scheule, Ronald K; Whitsett, Jeffrey A

American Journal of Respiratory & Critical Care Medicine; 2006, Vol. 173 Issue 12, p1342-1347, 6p

Gumlaw N; Sanofi, Framingham, MA 01701-9322, USA.; Sevigny LM; Sanofi, Framingham, MA 01701-9322, USA. Electronic address: leila.sevigny@sanofi.com.; Zhao H; Sanofi, Framingham, MA 01701-9322, USA.; Luo Z; Sanofi, Framingham, MA 01701-9322, USA.; Bangari DS; Sanofi, Framingham, MA 01701-9322, USA.; Masterjohn E; Sanofi, Framingham, MA 01701-9322, USA.; Chen Y; Sanofi, Framingham, MA 01701-9322, USA.; McDonald B; Sanofi, Framingham, MA 01701-9322, USA.; Magnay M; Sanofi, Framingham, MA 01701-9322, USA.; Travaline T; Sanofi, Framingham, MA 01701-9322, USA.; Yoshida-Moriguchi T; Sanofi, Framingham, MA 01701-9322, USA.; Fan W; Sanofi, Framingham, MA 01701-9322, USA.; Reczek D; Sanofi, Framingham, MA 01701-9322, USA.; Stefano JE; Sanofi, Framingham, MA 01701-9322, USA.; Qiu H; Sanofi, Framingham, MA 01701-9322, USA.; Beil C; Sanofi, Framingham, MA 01701-9322, USA.; Lange C; Sanofi, Framingham, MA 01701-9322, USA.; Rao E; Sanofi, Framingham, MA 01701-9322, USA.; Lukason M; Sanofi, Framingham, MA 01701-9322, USA.; Barry E; Sanofi, Framingham, MA 01701-9322, USA.; Brondyk WH; Sanofi, Framingham, MA 01701-9322, USA.; Zhu Y; Sanofi, Framingham, MA 01701-9322, USA.; Cheng SH; Sanofi, Framingham, MA 01701-9322, USA.

Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

Richmond JM; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Masterjohn E; Protein Production and Biology, Sanofi-Genzyme, Framingham, Massachusetts, USA.; Chu R; Protein Production and Biology, Sanofi-Genzyme, Framingham, Massachusetts, USA.; Tedstone J; Immunology and Inflammation Research, Sanofi-Genzyme, Framingham, Massachusetts, USA.; Youd ME; Immunology and Inflammation Research, Sanofi-Genzyme, Framingham, Massachusetts, USA.; Harris JE; Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. Electronic address: john.harris@umassmed.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

Turner MJ; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States. Electronic address: michael.turner@genzyme.com.; Pang PT; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Chretien N; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Havari E; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; LaMorte MJ; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Oliver J; Pathology, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Pande N; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Masterjohn E; Biologics Discovery, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Carter K; Biologics Discovery, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Reczek D; Biologics Discovery, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Brondyk W; Biologics Discovery, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Roberts BL; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Kaplan JM; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.; Siders WM; Neuroimmunology Research, Genzyme, a Sanofi company, 49 New York Avenue, Framingham, MA 01701, United States.

Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 8109498 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8421 (Electronic) Linking ISSN: 01655728 NLM ISO Abbreviation: J Neuroimmunol Subsets: MEDLINE